Recalls & Warnings October 12, 2020 Griffo Botanicals Warned for COVID-19 Claims On October 7, 2020, the FDA issued a warning letter to Griffo Botanicals for selling various herbal products, including BaseCamp, Gan Mao, Febris, Fortifend, Xiao Chai Hu, HuBei #1, Qing Fei Pai Du, Solis, and WuHan #2, with unsupported claims that they can treat coronavirus
In terms of its effects, it appears to impact drinking in ways (though not necessarily mechanisms) similar to naltrexone (FDA-approved) and topiramate (prescribed off label for alcohol use disorder), which have a greater effect in reducing intensity of drinking on drinking days relative to their effects on whether someone drinks at all (i.e., abstinent days) although all of them do increase abstinent days to some degree on average)
IV clinics and medical spas offer infusions
An Integrative Multiomics Approach to Characterize Anti-Adipogenic and Anti-Lipogenic Effects of Akkermansia Muciniphila in Adipocytes